LivaNova LIVN
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$3.97M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 37.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 8.57% to 11.55% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +829,580 | 7.2% |
| Invesco Ltd. | Mutual Fund | 2026/Q3 | +535,880 | 4.1% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +240,039 | 1.0% |
| BlackRock | Mutual Fund | 2026/Q3 | +174,322 | 14.0% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +155,226 | 1.2% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +113,564 | 0.2% |
| Barclays PLC | Public Company | 2026/Q3 | +93,722 | 0.5% |
| Principal Global Investors, LLC | Mutual Fund | 2026/Q3 | +68,815 | 0.5% |
| Mutual of America Capital Management LLC | Insurance Company | 2026/Q3 | +68,084 | 0.2% |
| Hood River Capital Management LLC | Mutual Fund | 2026/Q3 | +1,928,937 | 4.7% |
| FMR | Mutual Fund | 2026/Q3 | +480,197 | 5.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +426,434 | 13.7% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +361,857 | 0.9% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +257,877 | 3.2% |
| Invesco Ltd. | Mutual Fund | 2026/Q3 | +251,253 | 3.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 11 Nov 2026 | Alex Shvartsburg | Chief Financial Officer | Automatic Disposition | -2,500 | $90.91 | 42,147 |
| 14 Sep 2026 | Anne Liddy | Chief Legal Officer | Other Derivative Acquisition | +6,291 | – | 6,291 |
| 9 Sep 2026 | Francesco Bianchi | Independent Non-Executive Director | Open Market Disposition | -3,500 | $78.01 | 4,434 |
| 3 Sep 2026 | Brooke Story | Independent Director | Open Market Disposition | -2,300 | $81.42 | 7,488 |
| 1 Sep 2026 | Franco Poletti | Former President of Cardiopulmonary Business Unit | Intent to Sell (Form 144) | -10,755 | $82.09 | – |
| 30 Aug 2026 | Francesco Bianchi | Independent Non-Executive Director | Open Market Disposition | -1,650 | $79.72 | 7,934 |
| 10 Aug 2026 | Ahmet Tezel | Chief Innovation Officer | Derivative Exercise and Sale | -12,692 | $77.86 | 6,090 |
| 14 Jun 2026 | Todd Schermerhorn | Independent Non-Executive Director | Derivative Exercise and Sale | -486 | $79.70 | 12,619 |
| 14 Jun 2026 | Todd Schermerhorn | Independent Non-Executive Director | Other Derivative Acquisition | +2,383 | – | 2,383 |
| 14 Jun 2026 | Todd Schermerhorn | Independent Non-Executive Director | Derivative Exercise and Retained | +3,556 | – | 12,619 |
| 14 Jun 2026 | Peter Wilver | Independent Director | Derivative Exercise and Sale | -486 | $79.70 | 10,294 |
| 14 Jun 2026 | Peter Wilver | Independent Director | Other Derivative Acquisition | +2,383 | – | 2,383 |
| 14 Jun 2026 | Peter Wilver | Independent Director | Derivative Exercise and Retained | +3,556 | – | 10,294 |
| 14 Jun 2026 | William Kozy | Chairman of Board | Derivative Exercise and Sale | -682 | $79.70 | 37,566 |
| 14 Jun 2026 | William Kozy | Chairman of Board | Other Derivative Acquisition | +2,383 | – | 2,383 |
| 14 Jun 2026 | William Kozy | Chairman of Board | Derivative Exercise and Retained | +4,999 | – | 37,566 |
| 14 Jun 2026 | Stacy Seng | Independent Non-Executive Director | Derivative Exercise and Sale | -486 | $79.70 | 15,307 |
| 14 Jun 2026 | Stacy Seng | Independent Non-Executive Director | Other Derivative Acquisition | +2,383 | – | 2,383 |
| 14 Jun 2026 | Stacy Seng | Independent Non-Executive Director | Derivative Exercise and Retained | +3,556 | – | 15,307 |
| 14 Jun 2026 | Donald Zurbay | Independent Director | Derivative Exercise and Sale | -308 | $79.70 | 2,252 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 6,362,366 | 11.5% | 12.4 |
| 15 Oct 2026 | 6,199,576 | 11.3% | 10.6 |
| 30 Sep 2026 | 6,003,050 | 10.9% | 8.0 |
| 15 Sep 2026 | 5,375,448 | 9.8% | 9.7 |
| 31 Aug 2026 | 4,987,757 | 9.1% | 9.0 |
| 14 Aug 2026 | 4,721,380 | 8.6% | 5.4 |
No comments yet — be the first to weigh in on LIVN.
Sign in to join the discussion.